Bioresorbable Polymers Market to Reach USD 3.63 Billion by 2030 | DataM Intelligence

Rising Surgical Volumes and Medical Device Innovations Accelerate Market Growth

According to DataM Intelligence, the Global Bioresorbable Polymers Market was valued at USD 1.30 billion in 2022 and is projected to reach USD 3.63 billion by 2030, expanding at an impressive CAGR of 13.8% from 2023 to 2030. This strong growth is driven by increased surgical procedures worldwide, greater demand for biodegradable medical implants, and technological innovations in healthcare.

Bioresorbable polymers, also known as bioabsorbable polymers, are a specialized class of materials capable of being safely degraded and absorbed by the human body. These materials are widely used in sutures, stents, orthopedic implants, and drug delivery systems. Their ability to eliminate secondary surgical removal procedures significantly enhances patient outcomes while reducing healthcare costs-an essential factor fueling their global adoption.

Get a Free Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.datamintelligence.com/download-sample/bioresorbable-polymers-market?utm_source=OpenPR&utm_campaign=Onkar

Key Highlights from the Report

➤ Global market to reach USD 3.63 billion by 2030, growing at a CAGR of 13.8% (2023-2030).
➤ North America led the market in 2022 with a 32.5% revenue share.
➤ Asia Pacific anticipated to register the fastest CAGR of 15.9% through 2030.
➤ Polylactic acid (PLA) dominated the product segment, accounting for 29.5% share in 2022.
➤ Orthopedics was the largest application segment with 43.6% revenue share.
➤ Increasing use of bio-based raw materials and resorbable implants drives sustainable growth.

Market Segmentation

Product Type Insights

Polylactic acid (PLA) emerged as the largest product category in 2022, holding a 29.5% revenue share. PLA's superior biocompatibility and mechanical strength make it a preferred material in orthopedic fixation devices, including pins, screws, and washers. Its safe degradation into lactic acid eliminates the need for surgical removal, contributing to its broad adoption in biomedical applications.

The polyglycolic acid (PGA) segment is expected to grow at a CAGR of 14.1% through 2030. Its rapid biodegradation makes it ideal for drug delivery systems such as microspheres and nanofibers used to deliver proteins, chemotherapeutics, and vaccines. These bioresorbable polymer forms enable controlled medication release while minimizing patient discomfort and recovery times.

Application Insights

Orthopedics dominated the market with a 43.6% revenue share in 2022. The growing aging population, sedentary lifestyle, and increasing cases of arthritis and osteoporosis are driving the demand for orthopedic implants and resorbable devices. Bioresorbable materials are now extensively used in sutures, stents, and internal fixation systems.

The drug delivery segment, projected to register the fastest CAGR of 15.7%, is benefitting from rising chronic disease prevalence and growing investment in sustained-release technologies. The emergence of customized polymeric platforms, such as Evonik's RESOMER Precise, supports advanced parenteral drug formulations with accurate release profiles and improved bioavailability.

Get Customization in the Report as Per Your Business Requirements: https://www.datamintelligence.com/customize/bioresorbable-polymers-market?utm_source=OpenPR&utm_campaign=Onkar

Regional Insights

North America held the largest global revenue share of 32.5% in 2022 due to high healthcare expenditure, robust R&D capabilities, and growing utilization of bioresorbable devices across orthopedic and drug delivery applications. The U.S. healthcare sector performs more than 50 million surgeries annually, significantly driving product consumption.

Asia Pacific is predicted to witness the fastest growth, expanding at a CAGR of 15.9% through 2030, fueled by rapid healthcare investments, expanding hospital infrastructure, and a growing elderly population in countries like China and Japan. Supportive government initiatives, rise in per capita income, and demand for high-performance implants are promoting regional adoption.

Europe also holds a significant position, driven by regulatory focus on sustainable medical materials and technological collaborations for advanced surgical applications. Countries such as Germany and France are key contributors, prioritizing environmentally safe and patient-centric medical products.

Market Dynamics

Market Drivers:
Rising global surgical procedures, expanding applications in orthopedics and drug delivery, and the benefits of biocompatible and degradable materials are driving demand. The increased incidence of chronic diseases and availability of advanced, patient-safe implants further support steady growth.

Market Restraints:
High production costs, stringent regulatory requirements, and limited awareness in developing regions may hinder rapid market penetration. Additionally, the complex degradation behavior of some polymers presents engineering challenges for specific medical uses.

Market Opportunities:
Expanding innovations in bio-based raw materials, combined with advances in 3D printing and nanotechnology, are creating new opportunities in customized implant manufacturing. Emerging economies are expected to contribute significantly due to expanding healthcare access and infrastructure development.

Purchase This Exclusive Report at Just USD 5208 Only: https://www.datamintelligence.com/buy-now-page?report=bioresorbable-polymers-market?utm_source=OpenPR&utm_campaign=Onkar

Reasons to Buy the Report

✔ Provides data-driven insights into emerging opportunities and market potential.
✔ Highlights leading product categories, regional demand, and competitive landscape.
✔ Analyzes regulatory progress and technological advancements driving innovation.
✔ Outlines key mergers, acquisitions, and partnerships shaping industry growth.
✔ Supports strategic decision-making with detailed forecasts through 2030.

Frequently Asked Questions (FAQs)

◆ How big is the global bioresorbable polymers market in 2030?
◆ What is the CAGR of the bioresorbable polymers market from 2023 to 2030?
◆ Which region leads the global bioresorbable polymers market?
◆ What are the key applications driving market growth in orthopedics and drug delivery?
◆ Who are the top companies investing in bioresorbable polymer production?

Company Insights

Corbion N.V.

Evonik Industries AG

Poly‐Med Inc.

Foster Corp.

Abbott Laboratories

KLS Martin Group

3D Biotek LLC

Sunstar Suisse S.A.

DSM

Futerro

Recent Developments:

- In August 2021, Evonik Industries AG acquired JeNaCell, a German biotech company, expanding its biomaterials portfolio under the Nutrition & Care division to strengthen its medical solutions footprint.

- In June 2020, Evonik unveiled RESOMER Precise, a tailored polymer platform designed for controlled drug release and enhanced stability in injectable therapies.

Conclusion

The bioresorbable polymers market is rapidly evolving as healthcare industries move toward sustainable and patient‐centric solutions. Driven by unprecedented growth in orthopedic and drug delivery applications, supported by global healthcare modernization, this market is poised for robust expansion through 2030. Continued innovation, strategic partnerships, and growing adoption in emerging economies will further establish bioresorbable polymers as a cornerstone of modern medical material science.

Contact Us

Mr. Sai Kiran
DataM Intelligence 4market Research LLP Ground floor
DSL Abacus IT Park, Industrial Development Area
Uppal, Hyderabad, Telangana 500039
USA: +1 877-441-4866
Email: Sai.k@datamintelligence.com
Visit Our Website: https://www.datamintelligence.com

About Us

DataM Intelligence 4Market Research is a comprehensive market intelligence platform offering syndicated and customized reports along with expert consulting across multiple industries, including chemicals, healthcare, agriculture, food & beverages, and more. With extensive experience and a strategy-focused approach, DataM provides businesses and individuals with reliable market insights, statistical forecasts, and personalized research solutions to help them make informed decisions and successfully bring innovations to market.

This release was published on openPR.